Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Being specific about race-specific medicine.

Jonathan Kahn1, Pamela Sankar

  • 1Hamline University School of Law in St. Paul, Minnesota, USA.

Health Affairs (Project Hope)
|August 17, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary Extracellular Vesicles for High-Precision Bladder Cancer Subtyping and Prognosis.

Journal of extracellular biology·2026
Same author

Four Common Beliefs About Patient Memory Evaluations: Who Has Them and What Modifies Them?

American journal of Alzheimer's disease and other dementias·2026
Same author

Effects of caregiving experience on expectations of becoming an Alzheimer's disease caregiver in the future.

The journals of gerontology. Series B, Psychological sciences and social sciences·2026
Same author

An online vignette study of diagnostic testing: Racial and ethnic differences in Alzheimer's disease diagnosis confidence and stigma.

Alzheimer's & dementia (Amsterdam, Netherlands)·2025
Same author

Are Knowledge and Interpersonal Contact Cures for Alzheimer's Stigma? Data From Caregivers Offer Clues.

Stigma and health·2025
Same author

A survey study of Alzheimer's stigma among Black adults: intersectionality of Black identity and biomarker diagnosis.

Ethnicity & health·2024
Same journal

National Health Expenditure Projections, 2025-34: Strong Utilization Growth Initially, Legislative Impacts Later.

Health affairs (Project Hope)·2026
Same journal

State Medicaid Programs Face Increased Spending On Medicare Premiums.

Health affairs (Project Hope)·2026
Same journal

Not enough time.

Health affairs (Project Hope)·2026
Same journal

Medicaid Tobacco And Nicotine Cessation Treatment Rates Remained Low, 2019-24.

Health affairs (Project Hope)·2026
Same journal

Third-Party Convener Firms And The Rise Of Geographically Dispersed, High-Earning Medicare ACOs.

Health affairs (Project Hope)·2026
Same journal

The Opacity Of Price Transparency.

Health affairs (Project Hope)·2026
See all related articles

This study clarifies that prescribing BiDil or its generics should not be based on race. The analysis indicates that race-blind prescribing ensures appropriate patient care without denying life-saving therapies.

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Health Disparities

Background:

  • A previous analysis of BiDil prescribing practices was published.
  • Gary Puckrein's paper, "BiDil: From Another Vantage Point," critiqued this analysis.

Discussion:

  • Puckrein's paper misrepresents the original analysis.
  • The original analysis does not advocate for denying patients access to BiDil or its generics.
  • The evidence supports prescribing BiDil irrespective of patient race.

Key Insights:

  • The critique of the BiDil analysis by Puckrein is based on a misinterpretation.
  • The original analysis supports, rather than hinders, access to potentially life-saving therapies.
  • Prescribing decisions for BiDil should be race-neutral.

Related Experiment Videos

Outlook:

  • Further research into race-based medicine is warranted.
  • Clinical guidelines should emphasize evidence-based prescribing over racial categorizations.
  • Promoting equitable access to cardiovascular therapies is crucial.